Twin Capital Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.85M | Sell |
27,595
-396
| -1% | -$55.5K | 0.5% | 45 |
|
|
2025
Q4 | $3.44M | Sell |
27,991
-346
| -1% | -$42K | 0.43% | 56 |
|
|
2025
Q3 | $3.15M | Sell |
28,337
-4,987
| -15% | -$567K | 0.4% | 63 |
|
|
2025
Q2 | $3.69M | Buy |
33,324
+538
| +2% | +$57.3K | 0.39% | 67 |
|
|
2025
Q1 | $3.67M | Buy |
32,786
+2,392
| +8% | +$247K | 0.43% | 63 |
|
|
2024
Q4 | $2.81M | Buy |
30,394
+606
| +2% | +$54.6K | 0.31% | 85 |
|
|
2024
Q3 | $2.5M | Sell |
29,788
-467
| -2% | -$35.6K | 0.28% | 98 |
|
|
2024
Q2 | $2.08M | Buy |
30,255
+734
| +2% | +$49K | 0.24% | 112 |
|
|
2024
Q1 | $2.16M | Sell |
29,521
-2,204
| -7% | -$169K | 0.27% | 110 |
|
|
2023
Q4 | $2.57M | Buy |
31,725
+6,093
| +24% | +$474K | 0.34% | 86 |
|
|
2023
Q3 | $1.92M | Sell |
25,632
-1,386
| -5% | -$107K | 0.28% | 107 |
|
|
2023
Q2 | $2.08M | Sell |
27,018
-1,123
| -4% | -$89.6K | 0.27% | 109 |
|
|
2023
Q1 | $2.33M | Buy |
+28,141
| New | +$2.33M | 0.32% | 99 |
|
|
2022
Q1 | – | Sell |
-9,980
| Closed | -$725K | – | 282 |
|
|
2021
Q4 | $725K | Sell |
9,980
-730
| -7% | -$50.3K | 0.07% | 228 |
|
|
2021
Q3 | $748K | Buy |
10,710
+159
| +2% | +$11.2K | 0.08% | 233 |
|
|
2021
Q2 | $727K | Sell |
10,551
-199
| -2% | -$13.3K | 0.07% | 240 |
|
|
2021
Q1 | $695K | Sell |
10,750
-1,110
| -9% | -$71.6K | 0.07% | 240 |
|
|
2020
Q4 | $691K | Sell |
11,860
-849
| -7% | -$51.2K | 0.06% | 235 |
|
|
2020
Q3 | $803K | Sell |
12,709
-202
| -2% | -$14K | 0.07% | 226 |
|
|
2020
Q2 | $993K | Sell |
12,911
-173
| -1% | -$13.3K | 0.1% | 201 |
|
|
2020
Q1 | $978K | Buy |
13,084
+4,450
| +52% | +$307K | 0.11% | 191 |
|
|
2019
Q4 | $561K | Sell |
8,634
-200
| -2% | -$13K | 0.05% | 248 |
|
|
2019
Q3 | $560K | Sell |
8,834
-480
| -5% | -$31.4K | 0.04% | 244 |
|
|
2019
Q2 | $629K | Sell |
9,314
-28,026
| -75% | -$1.84M | 0.04% | 239 |
|
|
2019
Q1 | $2.43M | Sell |
37,340
-100
| -0.3% | -$6.65K | 0.12% | 204 |
|
|
2018
Q4 | $2.34M | Sell |
37,440
-5,515
| -13% | -$385K | 0.13% | 190 |
|
|
2018
Q3 | $3.32M | Buy |
42,955
+4,705
| +12% | +$355K | 0.15% | 177 |
|
|
2018
Q2 | $2.71M | Sell |
38,250
-42,990
| -53% | -$3.04M | 0.14% | 194 |
|
|
2018
Q1 | $6.13M | Sell |
81,240
-16,480
| -17% | -$1.31M | 0.32% | 108 |
|
|
2017
Q4 | $7M | Buy |
97,720
+890
| +0.9% | +$67.6K | 0.34% | 96 |
|
|
2017
Q3 | $7.84M | Buy |
96,830
+24,470
| +34% | +$1.87M | 0.41% | 74 |
|
|
2017
Q2 | $5.12M | Buy |
72,360
+3,450
| +5% | +$230K | 0.3% | 106 |
|
|
2017
Q1 | $4.68M | Sell |
68,910
-51,480
| -43% | -$3.62M | 0.29% | 108 |
|
|
2016
Q4 | $8.62M | Buy |
120,390
+6,330
| +6% | +$470K | 0.55% | 47 |
|
|
2016
Q3 | $9.02M | Sell |
114,060
-5,240
| -4% | -$426K | 0.6% | 40 |
|
|
2016
Q2 | $9.95M | Buy |
119,300
+410
| +0.3% | +$36.4K | 0.75% | 31 |
|
|
2016
Q1 | $10.9M | Buy |
118,890
+4,610
| +4% | +$416K | 0.85% | 30 |
|
|
2015
Q4 | $11.6M | Buy |
114,280
+11,590
| +11% | +$1.21M | 0.95% | 27 |
|
|
2015
Q3 | $10.1M | Buy |
102,690
+1,790
| +2% | +$199K | 0.96% | 24 |
|
|
2015
Q2 | $11.8M | Sell |
100,900
-5,700
| -5% | -$623K | 1.06% | 17 |
|
|
2015
Q1 | $10.5M | Buy |
106,600
+10,960
| +11% | +$1.11M | 0.92% | 22 |
|
|
2014
Q4 | $9.02M | Buy |
95,640
+6,340
| +7% | +$656K | 0.86% | 23 |
|
|
2014
Q3 | $9.51M | Buy |
89,300
+5,580
| +7% | +$546K | 0.96% | 18 |
|
|
2014
Q2 | $6.94M | Buy |
83,720
+320
| +0.4% | +$24.9K | 0.7% | 32 |
|
|
2014
Q1 | $5.91M | Buy |
83,400
+38,340
| +85% | +$3.01M | 0.62% | 36 |
|
|
2013
Q4 | $3.38M | Buy |
45,060
+13,180
| +41% | +$918K | 0.36% | 87 |
|
|
2013
Q3 | $2M | Buy |
31,880
+5,650
| +22% | +$338K | 0.21% | 143 |
|
|
2013
Q2 | $1.34M | Buy |
+26,230
| New | +$1.37M | 0.14% | 184 |
|
Other funds holding GILD
VCM
VPM
Twin Capital Management's GILD Position: Q1 2026 in Review
Twin Capital Management reduced its Gilead Sciences (GILD) stake by 1.4% in Q1 2026, selling an estimated $55.5K and leaving 27,595 shares worth $3.85M. The position accounts for 0.5% of the portfolio, ranked #45.
Twin Capital Management first reported a position in GILD in Q2 2013 and has held it in 48 quarters since. The position peaked at $11.8M in Q2 2015. 2,310 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Twin Capital Management held 27,595 shares of Gilead Sciences worth $3.85M as of Q1 2026.
- Twin Capital Management sold 396 Gilead Sciences shares in Q1 2026, an estimated $55.5K.
- Gilead Sciences made up 0.5% of Twin Capital Management's portfolio in Q1 2026, its #45 holding.
- Twin Capital Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 48 quarters since.
- Twin Capital Management's Gilead Sciences position peaked at $11.8M in Q2 2015.
- 2,310 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Twin Capital Management's 13F filing for Q1 2026, filed 5 May 2026.